Ser15-phospho-p53 marks activated p53
[DOI] [PubMed] [Google Scholar] [175].Medina B, Girard ID, Jacotot E, Julliand V
HCPCS J-codes typically define a specific unit of measurement (such as per 1mg or per 0.1mg)
We have not observed concerning signs of muscle weakness in clinical trials to date." The company said 11.3 percent of patients on the highest dose during retatrutide's clinical trial stopped taking the drug during the study because of significant side effects: nausea, diarrhea, constipation, vomiting and upper respiratory tract infection
Common adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, and constipation, which typically diminish over time